Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform

Source Domain: www.nature.com

Here’s a summarized list of key points from the provided article references on drug discovery and development:

Fundamental Principles: Key articles discuss the basic principles and stages of drug discovery and development, including hit identification, lead optimization, and the principles of early drug discovery.
Virtual Screening Techniques: Several papers highlight the use of virtual screening methods, including docking algorithms, ligand-based and structure-based approaches, and the use of machine learning for virtual screening.
Advancements in Computational Methods: Recent advances in computational techniques for drug discovery, including the use of AI and deep learning models such as AlphaFold for protein structure prediction and docking methods for identifying potential drug candidates.
Tools and Databases: Important databases and tools are discussed, such as DrugBank for in silico drug discovery, RDKit for cheminformatics, and the RCSB Protein Data Bank (RCSB PDB) for experimentally determined protein structures.
Evaluation and Benchmarking: Several articles focus on the evaluation and benchmarking of virtual screening methods, docking algorithms, and machine learning models to predict protein-ligand interactions and binding affinities.
Challenges and Bias: Discussions on challenges like hidden biases in datasets, the generalizability of docking predictions, and the limitations of AI-based docking methods are prevalent.
Emerging Technologies: The emergence of deep learning paradigms and AI-driven platforms for virtual screening, along with advancements in protein-ligand interaction prediction using novel methods like geometric deep learning and structure-based molecular docking.
Applications in Real Drug Discovery: Examples of practical applications of the discussed techniques in real-world drug discovery scenarios, including the discovery of novel inhibitors for specific targets through virtual screening.